In last trading session, Vallon Pharmaceuticals Inc. (NASDAQ:VLON) saw 0.22 million shares changing hands with its beta currently measuring 0. Company’s recent per share price level of $0.25 trading at $0.01 or 5.93% at ring of the bell on the day assigns it a market valuation of $3.23M. That closing price of VLON’s stock is at a discount of -3316.0% from its 52-week high price of $8.54 and is indicating a premium of 16.0% from its 52-week low price of $0.21. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.13 million shares which gives us an average trading volume of 338.31K if we extend that period to 3-months.
Vallon Pharmaceuticals Inc. (NASDAQ:VLON) trade information
Upright in the green during last session for gaining 5.93%, in the last five days VLON remained trading in the red while hitting it’s week-highest on Thursday, 11/17/22 when the stock touched $0.25 price level, adding 13.61% to its value on the day. Vallon Pharmaceuticals Inc.’s shares saw a change of -95.76% in year-to-date performance and have moved -9.40% in past 5-day. Vallon Pharmaceuticals Inc. (NASDAQ:VLON) showed a performance of -23.10% in past 30-days. Number of shares sold short was 0.14 million shares which calculate 0.38 days to cover the short interests.
Vallon Pharmaceuticals Inc. (VLON) estimates and forecasts
Statistics highlight that Vallon Pharmaceuticals Inc. is scoring comparatively higher than the scores of other players of the relevant industry. The company lost -52.13% of value to its shares in past 6 months, showing an annual growth rate of 30.28% while that of industry is 4.60. Apart from that, the company came raising its revenue forecast for fiscal year 2022.
Vallon Pharmaceuticals Inc. is more likely to be releasing its next quarterly report between February 13 and February 17 and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.
Vallon Pharmaceuticals Inc. (NASDAQ:VLON)’s Major holders
Insiders are in possession of 55.05% of company’s total shares while institution are holding 21.45 percent of that, with stock having share float percentage of 47.73%. Investors also watch the number of corporate investors in a company very closely, which is 21.45% institutions for Vallon Pharmaceuticals Inc. that are currently holding shares of the company. Renaissance Technologies, LLC is the top institutional holder at VLON for having 78888.0 shares of worth $50464.0. And as of Jun 29, 2022, it was holding 0.75% of the company’s outstanding shares.
The second largest institutional holder is Two Sigma Investments, LP, which was holding about 42392.0 shares on Jun 29, 2022. The number of shares represents firm’s hold over 0.40% of outstanding shares, having a total worth of $27118.0.
On the other hand, Vanguard Extended Market Index Fund and Fidelity NASDAQ Composite Index Fund are the top two Mutual Funds which own company’s shares. As of Jun 29, 2022, the former fund manager was holding 22146.0 shares of worth $14166.0 or 0.21% of the total outstanding shares. The later fund manager was in possession of 9542.0 shares on Jun 29, 2022, making its stake of worth around $6104.0 in the company or a holder of 0.09% of company’s stock.